Scroll
To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

*Important

The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.


Association Francophone ds Glycogenoses


Address

34 allée du thym
83160 La valette du var
Corenc, 38700 France

Phone

330476410664

Email Address

afg@glycogenoses.org

Description

The Association Francophone ds Glycogenoses (AFG) is a unique organization dedicated to assisting individuals and families affected by a rare group of genetic diseases that impair the body's ability to metabolize or break down glycogen (glycogenesis). Termed "glycogen storage diseases," these familial disorders are characterized by the abnormal accumulation of glycogen in various organs of the body. Symptoms vary greatly depending upon the specific organ systems that are affected, and may include muscle weakness without loss of muscle mass (atrophy), abnormal enlargement of the heart (cardiomegaly), liver (hepatomegaly), and/or tongue (macroglossia), as well as heart and kidney problems. These diseases include (but are not limited to) Von Gierke disease (type 1), Cori disease (type III), Andersen disease (type IV), and Pompe disease (type II). Established in 1992, the association is dedicated to identifying families affected by these diseases and providing appropriate information about the different forms of the disease. In addition, the Association Francophone Des Glycogenoses is interested in stimulating ongoing research into the treatment and potential cure of these disorders.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.